Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-Year Continuation Rate of Etonogestrel Subdermal Implant and Associated Factors
TCTR20180405003Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of etonogestrel in contraception, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Primary endpoint: Three-year continuation rate of etonogestrel subdermal implant. Started May 2017; status: completed.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20180405003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180405003.